BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3193607)

  • 1. [Problems in using survival data of cancer patients as a method of gauging the effectiveness of cancer control efforts].
    Oshima A
    Gan No Rinsho; 1988 Oct; 34(12):1637-41. PubMed ID: 3193607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic issues in population screening for cancer.
    Cole P; Morrison AS
    J Natl Cancer Inst; 1980 May; 64(5):1263-72. PubMed ID: 6767876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer screening: the clash of science and intuition.
    Kramer BS; Croswell JM
    Annu Rev Med; 2009; 60():125-37. PubMed ID: 18803476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
    Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
    Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention: screening for breast cancer.
    Chamberlain J
    Eff Health Care; 1985; 2(5):179-88. PubMed ID: 10271344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    Otto SJ; Schröder FH; de Koning HJ
    J Med Screen; 2004; 11(2):89-92. PubMed ID: 15153324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evolution of cancer mortality. Reflexions of a physician].
    Israël L
    Bull Cancer; 1991; 78(4):313-5. PubMed ID: 1859899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term trends in cancer mortality in the United States, 1930-1998.
    Wingo PA; Cardinez CJ; Landis SH; Greenlee RT; Ries LA; Anderson RN; Thun MJ
    Cancer; 2003 Jun; 97(12 Suppl):3133-275. PubMed ID: 12784323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in cancer control in Wisconsin.
    Quenan L; Remington P
    WMJ; 2000 Jun; 99(3):34-8. PubMed ID: 10927979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the effects of lead-time bias, length bias and over-detection in evaluating screening mammography: a censored bivariate data approach.
    Mahnken JD; Chan W; Freeman DH; Freeman JL
    Stat Methods Med Res; 2008 Dec; 17(6):643-63. PubMed ID: 18445697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of cancer screening in end-stage renal disease.
    Chertow GM; Paltiel AD; Owen WF; Lazarus JM
    Arch Intern Med; 1996 Jun; 156(12):1345-50. PubMed ID: 8651845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in selective under-ascertainment bias in population-based estimates of cancer patient survival by age adjustment.
    Brenner H; Hakulinen T
    Eur J Cancer; 2005 Aug; 41(12):1788-93. PubMed ID: 16043349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of survival rates and number of patients with malignant neoplasms surviving for a long time after treatment at the National Cancer Center Hospital.
    Shiraishi M; Kitagawa C
    Jpn J Clin Oncol; 1983 Jun; 13(2):379-93. PubMed ID: 6887558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.
    Jemal A; Clegg LX; Ward E; Ries LA; Wu X; Jamison PM; Wingo PA; Howe HL; Anderson RN; Edwards BK
    Cancer; 2004 Jul; 101(1):3-27. PubMed ID: 15221985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The science of early detection.
    Kramer BS
    Urol Oncol; 2004; 22(4):344-7. PubMed ID: 15283894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of survival differences between clinically and screen-detected cancer patients.
    Habbema JD; van Oortmarssen GJ; van Putten DJ
    Stat Med; 1983; 2(2):279-85. PubMed ID: 6648143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional efforts to prevent malignant neoplasms in Japan with a focus on the statistics.
    Inoue K; Fujita Y; Iwamoto T; Nishimura M; Fukunaga T
    West Indian Med J; 2011 Dec; 60(6):694. PubMed ID: 22512234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.